Why does the goalkeeper eschew medication? The challenge of new treatments for tourette syndrome
2018; Wiley; Volume: 33; Issue: 8 Linguagem: Inglês
10.1002/mds.91
ISSN1531-8257
Autores Tópico(s)Autism Spectrum Disorder Research
ResumoMovement DisordersVolume 33, Issue 8 p. 1236-1237 Editorial Why does the goalkeeper eschew medication? The challenge of new treatments for tourette syndrome John L. Waddington PhD, DSc, Corresponding Author John L. Waddington PhD, DSc jwadding@rcsi.ie Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, IrelandCorresponding author: Dr. John L. Waddington, Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, St. Stephen's Green, Dublin 2, Ireland; jwadding@rcsi.ieSearch for more papers by this author John L. Waddington PhD, DSc, Corresponding Author John L. Waddington PhD, DSc jwadding@rcsi.ie Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, IrelandCorresponding author: Dr. John L. Waddington, Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, St. Stephen's Green, Dublin 2, Ireland; jwadding@rcsi.ieSearch for more papers by this author First published: 19 September 2018 https://doi.org/10.1002/mds.91Citations: 3 Relevant conflicts of interests/financial disclosures: Nothing to report. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume33, Issue8August 2018Pages 1236-1237 RelatedInformation
Referência(s)